In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation

CMV associated tissue-invasive disease is associated with a considerable risk of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). Recently, the terminase inhibitor letermovir (LMV) has been approved for prophylaxis of CMV infection in HSCT. We hereby report a...

Descripción completa

Detalles Bibliográficos
Autores principales: Frietsch, Jochen J, Michel, Detlef, Stamminger, Thomas, Hunstig, Friederike, Birndt, Sebastian, Schnetzke, Ulf, Scholl, Sebastian, Hochhaus, Andreas, Hilgendorf, Inken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328044/
https://www.ncbi.nlm.nih.gov/pubmed/30671207
http://dx.doi.org/10.4084/MJHID.2019.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328044/
https://www.ncbi.nlm.nih.gov/pubmed/30671207
http://dx.doi.org/10.4084/MJHID.2019.001

Ejemplares similares